Am J Obstet Gynecol:研究揭示产妇糖尿病诱发胎儿的机制

2017-11-18 Emma MedSci原创

神经管缺陷是一种严重的畸形疾病,神经管就是胎儿的中枢神经系统。中枢神经管是胚胎发育成脑、脊髓、头颅背部和脊椎的部位,如果中枢神经管不能正常发育,在婴儿出生时,上述部位就可能出现缺陷。

神经管缺陷是一种严重的畸形疾病,神经管就是胎儿的中枢神经系统。中枢神经管是胚胎发育成脑、脊髓、头颅背部和脊椎的部位,如果中枢神经管不能正常发育,在婴儿出生时,上述部位就可能出现缺陷。氧化应激是产妇糖尿病诱发神经管缺陷(NTDs)的关键因素,氧化还原基因Nrf2(核因子-红细胞2-相关因子2)是细胞抗氧化系统的主要调节剂。因此研究人员调查了目前母体糖尿病是否通过氧化还原敏感的miR-27a抑制Nrf2表达以及Nrf2控制的抗氧化基因。

研究人员发现,糖尿病母体E8.5胚胎中Nrf2的mRNA和蛋白质水平显著低于非糖尿病母体,而miR-27a上调,神经干细胞体外试验中,高葡萄糖还以剂量和时间依赖性方式显著增加miR-27a水平,降低Nrf2表达。在体内和体外试验中Nrf2控制的抗氧化酶谷氨酸-半胱氨酸连接酶催化亚基(GCLC),谷氨酸- cyteine连接酶修饰亚基(GLCM)和谷胱甘肽S-转移酶A1(GSTA1)均下调。miR-27a抑制剂能够消除了高糖对Nrf2表达的抑制作用,miR-27a模拟物能够抑制神经干细胞中的Nrf2表达。当抑制miR-27a时能够恢复了GCLC,GLCM和GSTA1的表达,过表达SOD2能够逆转母体糖尿病诱导的miR-27a增加和抑制Nrf2和Nrf2控制的抗氧化酶。

研究人员通过链脲佐菌素诱导1型糖尿病胚胎病小鼠模型来进行研究,并收获E8.5胚胎用于分析Nrf2以及Nrf2控制的抗氧化剂基因和miR-27a表达。应用SOD2(线粒体相关的抗氧化剂基因)过表达糖尿病胚胎病变的小鼠模型,调查减轻氧化应激是否能够抑制miR-27a增加和降低Nrf2表达,得到的结果是减轻氧化应激能够抑制miR-27a增加和降低Nrf2表达。在正常和高糖条件下培养C17.2神经干细胞,并检测miR-27a和Nrf2之间的关系也得到与小鼠模型相同的结果。

该研究表明,母体糖尿病诱导的氧化应激增加了miR-27a,抑制了Nrf2及其反应性抗氧化酶,导致糖尿病胚胎病变,这为相关疾病的治疗提供了重要参考。

原始出处:
Zhao Y, et al. Oxidative stress-induced miR-27a targets the redox gene Nrf2 in diabetic embryopathy. Am J Obstet Gynecol. 2017 Oct 31. pii: S0002-9378(17)31233-4. doi: 10.1016/j.ajog.2017.10.040.

本文系梅斯医学(MedSci)原创翻译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2044023, encodeId=9f752044023f9, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat May 26 08:34:00 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034155, encodeId=e4fe2034155e9, content=<a href='/topic/show?id=7459244954a' target=_blank style='color:#2F92EE;'>#产妇糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24495, encryptionId=7459244954a, topicName=产妇糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=310e209, createdName=yzh399, createdTime=Sun Feb 04 10:34:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011354, encodeId=5876201135430, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Sep 06 09:34:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262304, encodeId=190f26230462, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Sat Nov 18 16:26:39 CST 2017, time=2017-11-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2044023, encodeId=9f752044023f9, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat May 26 08:34:00 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034155, encodeId=e4fe2034155e9, content=<a href='/topic/show?id=7459244954a' target=_blank style='color:#2F92EE;'>#产妇糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24495, encryptionId=7459244954a, topicName=产妇糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=310e209, createdName=yzh399, createdTime=Sun Feb 04 10:34:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011354, encodeId=5876201135430, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Sep 06 09:34:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262304, encodeId=190f26230462, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Sat Nov 18 16:26:39 CST 2017, time=2017-11-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2044023, encodeId=9f752044023f9, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat May 26 08:34:00 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034155, encodeId=e4fe2034155e9, content=<a href='/topic/show?id=7459244954a' target=_blank style='color:#2F92EE;'>#产妇糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24495, encryptionId=7459244954a, topicName=产妇糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=310e209, createdName=yzh399, createdTime=Sun Feb 04 10:34:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011354, encodeId=5876201135430, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Sep 06 09:34:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262304, encodeId=190f26230462, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Sat Nov 18 16:26:39 CST 2017, time=2017-11-18, status=1, ipAttribution=)]
    2018-09-06 zhaojie88
  4. [GetPortalCommentsPageByObjectIdResponse(id=2044023, encodeId=9f752044023f9, content=<a href='/topic/show?id=8513126129d' target=_blank style='color:#2F92EE;'>#NEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12612, encryptionId=8513126129d, topicName=NEC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1ac22500003, createdName=1249842em09(暂无昵称), createdTime=Sat May 26 08:34:00 CST 2018, time=2018-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2034155, encodeId=e4fe2034155e9, content=<a href='/topic/show?id=7459244954a' target=_blank style='color:#2F92EE;'>#产妇糖尿病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24495, encryptionId=7459244954a, topicName=产妇糖尿病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=310e209, createdName=yzh399, createdTime=Sun Feb 04 10:34:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2011354, encodeId=5876201135430, content=<a href='/topic/show?id=840d1e300e5' target=_blank style='color:#2F92EE;'>#TET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17300, encryptionId=840d1e300e5, topicName=TET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Sep 06 09:34:00 CST 2018, time=2018-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=262304, encodeId=190f26230462, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18741984753, createdName=smartxiuxiu, createdTime=Sat Nov 18 16:26:39 CST 2017, time=2017-11-18, status=1, ipAttribution=)]
    2017-11-18 smartxiuxiu

    学习

    0